This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Shire Human Genetic Therapies, Inc.. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Bruce Tangarone: Innovator in Lipoprotein Lipase Therapy
Introduction
Bruce Tangarone is a notable inventor based in Hampstead, NH (US). He has made significant contributions to the field of medical therapies, particularly in the treatment of hypertriglyceridemic-related conditions. His work focuses on developing innovative solutions to combat serious health issues.
Latest Patents
Bruce Tangarone holds a patent for a lipoprotein lipase (LPL) protein aimed at treating and preventing hypertriglyceridemia (HTG) and its associated diseases. This includes conditions such as acute pancreatitis, cardiovascular diseases, metabolic disorders, endocrine disorders, and fat embolism syndrome. His patent addresses the urgent need for effective treatments for these serious health conditions.
Career Highlights
Bruce is currently employed at Shire Human Genetic Therapies, Inc., where he continues to advance his research and development efforts. His work has the potential to significantly impact the lives of individuals suffering from hypertriglyceridemia and related diseases.
Collaborations
Throughout his career, Bruce has collaborated with talented professionals, including Omar L. Francone and Lin Guey. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Bruce Tangarone's contributions to the field of lipoprotein lipase therapy exemplify the importance of innovation in addressing critical health challenges. His work not only advances medical science but also offers hope for patients affected by hypertriglyceridemia and its associated conditions.